TD Cowen analysts maintained a positive outlook on Datadog (NASDAQ:DDOG), reiterating their Buy rating and setting a price target of $165.00. The firm anticipates a strong finish for Datadog's fourth ...

In a report released today, Gautam Khanna from TD Cowen maintained a Hold rating on Hexcel (HXL – Research Report), with a price target of ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report) today and set a price target of ...

NEW YORK (AP) — A U.S. watchdog is suing Capital One for allegedly misleading consumers about its offerings for high-interest ...

Schlumberger (NYSE:SLB – Free Report) had its price objective decreased by TD Cowen from $65.00 to $53.00 in a research report report published on Wednesday morning,Benzinga reports. TD Cowen ...

Tuesday, analysts at TD Cowen began coverage on CG Oncology (NASDAQ:CGON) shares with a Buy rating, expressing confidence in the company's future prospects. The company, currently valued at $2.01 ...

TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...

On Monday, TD Cowen's analysts increased their price target on United Continental (NASDAQ:UAL) shares, moving the goal from $125.00 to $142.00 while maintaining a Buy rating. According to ...

Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to $324.00 in a research note issued to investors on Friday,Benzinga reports.

Fintel reports that on January 5, 2025, TD COWEN downgraded their outlook for Anheuser-Busch InBev (JSE:ANH) from Buy to Hold. There are 313 funds or institutions reporting positions in Anheuser ...

Investing.com-- TD Cowen analysts have increased their price target for Butterfly Network (LON:NETW), Inc (NYSE:BFLY), citing robust momentum in the global rollout of its iQ3 handheld ultrasound ...

Investing.com-- TD Cowen analysts have increased their price target for Butterfly Network, Inc (NYSE:BFLY), citing robust momentum in the global rollout of its iQ3 handheld ultrasound device.